Chromosomal genes conferring resistance to trimethoprim were transferred from three independently isolated thy+ clinical strains of Escherichia coli to Escherichia coli K 12 by using P 1 transduction. Trimethoprim-resistant transductants were obtained less frequently than transductants of other chromosomal markers, suggesting that there were problems related to the expression of the trimethoprim resistance genes in E. coli K12. Mapping studies revealed that one of the resistance determinants was located at a similar position on the chromosome (1 min) to the fol-type mutations previously described in E. coli K12. The two remaining resistance determinants mapped at separate positions between 2.5 and 3 min on the chromosome. The presence of one of these determinants reduced the efficiency with which either donor or recipient cells carrying it could participate in conjugation mediated by the sex factor F and also resulted in phenotypic interaction with the azi gene. The mechanisms of trimethoprim resistance in the three clinical E. coli isolates studied were more complex and diverse than was expected from previous studies of E. coli K12 mutants. t Present address: Food Research Institute, Colney Lane, Norwich NR4 7UA, U.K. 0022-1287/83/0001-0561 $02.00 0 1983 SGM Downloaded from www.microbiologyresearch.org by
INTRODUCTION
Since the introduction of trimethoprim for clinical use there have been reports of a number of different forms of resistance in isolates of Escherichia coli. Resistance to trimethoprim may result from (i) the acquisition of a plasmid coding for trimethoprim resistance , such resistance sometimes being transposable (Barth et al., 1976) , (ii) the presence of a chromosomally located trimethoprim resistance transposon in the absence of a plasmid (Towner, 1981) , (iii) a mutation to thymine auxotrophy (Maskell et al., 1977) or (iv) mutations in other chromosomal genes (Grey et al., 1979) .
Trimethoprim resistance in thy+ E. coli K12 strains which have been either trained to resistance by sequential subculture in increasing concentrations of the drug (Breeze et al., 1975) or isolated following mutagenesis as resistant mutants on trimethoprim-containing medium (Sheldon & Brenner, 1976) , has been shown to be determined by mutations in the for gene, coding for production of the enzyme dihydrofolate reductase, located at about 1 min on the E. coli K12 linkage map (Bachmann & Low, 1980) . Resistance to trimethoprim in thy+ clinical isolates of E. coli which do not carry either a resistance plasmid or a chromosomally located transposon has been assumed to be determined in the same way, although this has not been investigated by genetic techniques.
We attempted to transfer chromosomal trimethoprim resistance from thy+ clinical isolates of E. coli to the well-characterized genetic background of E. coli K12 using, where possible, P1mediated generalized transduction. It was hoped that subsequent genetic analysis would not only show whether findings concerning artificially induced trimethoprim resistance in E. coli K12 were relevant to resistance in strains isolated from human infections, but also throw light upon the factors that may influence the genetic variation and interchange of chromosomal genes in wild strains of E. coli.
METHODS
Bacteria, plasmids and bacteriophages. Clinical strains of Escherichia coli (339 thy+ strains) isolated mainly from samples of infected urine received at the Public Health Laboratory, Nottingham, were investigated in this study.
Of these 53 were trimethoprim-resistant (MIC 2 8 mg 1-1 ; tested as below), but had previously been shown not to contain transferable trimethoprim R plasmids or trimethoprim resistance transposons when tested as described by Towner et al. (1982) . Strains of E. coli K12 and the clinical E. coli isolates used in gene transfer experiments are listed in Table 1 . Also used in conjugation experiments was the P incompatibility group plasmid RP4 (Datta et al., 1971) . Bacteriophages used were P l~ (Miller, 1972) , P1 clrIOOKM (Goldberg et al., 1974) , MS2 (Davis et al., 1961) and R17 (Miller, 1972) .
Media. Oxoid nutrient broth (NB), nutrient agar (NA) and sensitivity test agar (DST) were used. Lysed horse blood (4%, v/v) was added when trimethoprim was incorporated into DST. The E. coli minimal medium (MM) used was that of Vogel & Bonner (1956) , supplemented, where necessary, by amino acids (50 mg 1-l) and vitamins (1 mg 1-1). Unless otherwise stated, glucose (03%, w/v) was added as the carbon source. R plates were made from NA containing 2 x M-CaC1, plus 0.8% Davis agar, dispensed in 2.5 ml amounts. MC medium consisted of 0.1 M-MgSO, and 0-005 M-CaCl,. Resistance to azide was determined on NA containing 0.005 M-SodiUm azide.
Trimethoprim MIC determinations. NB cultures (1 0 ml) of the test organisms, incubated overnight at 37 "C, were diluted in 1/4 Ringer's solution. MIC values were determined using multipoint inoculation (with a final inoculum of about 100 c.f.u.) on to DST agar containing 4% (v/v) lysed horse blood and doubling dilutions of trimethoprim lactate (Burroughs Wellcome). Plates were examined following overnight incubation at 37 "C and the MIC taken to be the lowest concentration of the drug which prevented growth of the organism.
Determination of bacteriophage sensitivities. The surface of an R plate was inoculated with a single streak of an overnight NB culture of the strain to be tested. Six to eight strains could be tested per plate. A drop of bacteriophage lysate was spotted on to each streak and the plates examined after overnight incubation at 37 "C for inhibition of growth in the area of the spot. In doubtful cases, sensitivity was additionally tested by spotting a drop of bacteriophage lysate on to a lawn of bacterial cells prepared by inoculating R-top agar with 0-1 ml of an overnight NB culture and pouring this on to the surface of an R plate. Bacteriophage sensitivity was indicated by confluent lysis or the formation of plaques following overnight incubation at 37 "C.
Direct selection for PI-sensitive mutants. P1 -sensitive mutants of trimethoprim-resistant clinical isolates of E. coli which were normally insensitive were selected using P1 cZrIOOKM as described by Goldberg et al. (1974) .
Preparation and use of PI transducing lysates. These experiments were carried out using standard procedures for the use of P1 as described by Miller (1972) . Selection for the transduction of amino acid or vitamin markers into an auxotrophic recipient was made on glucose MM containing all the necessary growth requirements except the one under test. Transduction of the ara+ marker into an ara recipient was selected by substituting arabinose (0-5%, M-CaCl,. R-top agar was NB with 2 x (1980) This paper w/v) for glucose as the carbon source; a similar method was used for other sugar markers. Transductants were purified by re-streaking on to fresh plates of the same medium. Single colonies were then applied as a grid to the same medium (50 per plate), and replica plating was used to test for unselected marker inheritance. It proved impossible to select directly for azi' transfer in transduction experiments owing to heavy background growth when large numbers of cells were plated. The presence or absence of azi' as an unselected marker in transductants was tested by inoculating single colonies to plates of NA containing 0.005 M-sodiUm azide by using a single streak (four tests per plate). When tested in this manner, azide-sensithe transductants failed to show any growth after overnight incubation at 37 "C, while transductants carrying the azi' marker produced growth over the entire length of the streak.
Conjugation techniques. Fresh overnight NB cultures of the donor and recipient strains were subcultured (0.1 ml culture : 10 ml NB) and grown at 37 "C to late-exponential phase (4-5 h). Samples (3 ml) of each were then mixed and incubation continued at 37 "C for the time indicated. For crosses other than those involving an Hfr donor, extra aeration was not found to be necessary. For matings between Hfr and Fcells, cultures were incubated in 100 ml conical flasks in a shaking water bath to provide gentle aeration. Controls of each parent alone were included in all crosses. After incubation, the mating mixtures were centrifuged (5000 g for 20min), washed once and resuspended in 1/4 Ringer's solution. Portions (0.1 ml) of appropriate dilutions were then spread over selection plates and incubated at 37 "C. Transconjugants were tested for the inheritance of unselected markers as described for PI transductants.
RESULTS

Sensitivity of clinical E. coli isolates to P1
In order to determine whether P1 transduction was a feasible means of transferring genes from clinical isolates of E. coli and, in addition, to determine the overall proportion of P1sensitive isolates, 339 thy+ clinical strains of E. coli were tested with Pl* propagated on 553.2. Ninety-four (28%) of the 339 strains tested were sensitive to P1, but only one (GH9) of the 53 trimethoprim-resistant strains was P 1 -sensitive, indicating that the proportion of clinical isolates which were resistant to trimethoprim and also sensitive to P1 was low compared to the overall population of clinical E. coli strains.
To examine the basis of trimethoprim resistance in a range of isolates exhibiting various MIC values, an attempt was made to select for P1-sensitive mutants within populations of trimethoprim-resistant organisms which were normally resistant to P1. Two further P l-sensitive E. coli strains that were resistant to trimethoprim were isolated (GH64 and GH118) by the technique of Goldberg et al. (1974) .
Transduction of trimethoprim resistance from clinical isolates of E. coli into E. coli K12 and its subsequent expression
Lysates of P1 were prepared on cultures of donor bacteria (GH9, GH64 and GH118) and transductions performed using strain 553.2 as recipient. Selection for transfer of trimethoprim resistance was initially made on appropriately supplemented MM using a range of drug concentrations up to the MIC of the donor strain. However, it was found that no trimethoprimresistant transductants were obtained, whatever the MIC of the donor, when more than 8 mg trimethoprim 1-l was incorporated into the medium. This concentration was therefore routinely used in all subsequent transduction experiments.
Transduction of trimethoprim resistance from the clinical isolates of E. coli to E. coli K12 appeared to be a relatively rare event, possibly because the clinical isolates yielded only low titre lysates of P1 (Table 2 ). In a sequence of experiments using GH9, GH64 and GH118 as donors, trimethoprim-resistant transductants were obtained at a frequency varying between 5 x 1 0-6 and 1 x transductants per p.f.u., whereas transduction of auxotrophic markers from the clinical isolates to 553.2 seemed to occur more readily (Table 2) . Although the numbers of trimethoprim-resistant transductants obtained were small, control experiments showed that no colonies were obtained when 553.2 alone was plated on medium containing 8 mg trimethoprim 1-l and a separate experiment determined that the frequency of spontaneous mutation of 553.2 to resistance to this concentration of the drug was approximately 2 x 10-l l . As the number of cells routinely plated in each transduction experiment was approximately 1 08, there was Resistant transductants were purified and tested to ensure that they retained the characteristics of 553.2. Their trimethoprim MIC values were then determined and compared on the same plate with the MIC of the original donor strain. Although in the initial experiments no transductants were obtained on selection plates containing trimethoprim concentrations in excess of 8 mg 1-l, after purification, transductants obtained using any of the three donors were found to have an MIC of 32 mg 1-1 ; however, for GH64 and GH118 this was still below the value exhibited by the original donor strain (Table 1 ). More than one gene might be involved in conferring a higher level of resistance in GH64 and GH118, but attempts to use the resistant transductants from the initial experiments as recipients in further transductions, with selection on medium containing 64 mg trimethoprim 1-l, failed to produce any recombinants with an increased MIC.
It was recognized that the resistance determinants transferred into 553.2 might not be a single gene or might correspond to previously described genes in E. coli K12; however, for clarity in presentation, the trimethoprim resistance determinants transferred from GH9, GH64 and GH 1 18 were temporarily designated tim-1, tim-2 and tim-3 , respectively, and these designations will be used in the remainder of this paper.
Possible factors influencing the yield of transductants
In order to examine whether the action of the restriction/modification system of E. coli K12 was responsible for limiting the yield of transductants, the initial experiments were repeated with GH9, GH64 and GH118 as donors and using 553.2 and the restrictionless strain 2K--as recipients. No significant increase in the recovery of trimethoprim-resistant transductants was obtained using 2K--.
A second possibility, especially in view of the MIC results, was that the determinants encoding resistance to trimethoprim were not immediately expressed in E. coli K12. Breeze et al. (1 975) found that whenfol mutations were transduced between strains of E. coli K12, the yield of transductants was increased by allowing two cycles of division following infection with P1 before plating out. This was tested by carrying out duplicate sets of transductions in which one set of samples was plated out immediately, while extra growth medium (0.1 ml NB) was added to the remaining mixture and incubation continued at 37 "C. At hourly intervals (up to 4 h) further samples were transferred to trimethoprim selection plates. No increase was observed in the numbers of transductants obtained when post-transduction growth was allowed compared with the numbers obtained after immediate plating.
Attempts to produce Hfr strains carrying the trimethoprim resistance determinants
For preliminary mapping of the trimethoprim resistance determinants by conjugation experiments, resistance was transduced from the original 553.2 transductants to the HfrC strain CSH61. No difficulty was experienced in transducing the tim-2 and tim-3 determinants to CSH61 and the resulting transductants continued to act as Hfr-type donors and exhibit sensitivity to the F-specific bacteriophages MS2 and R17. In contrast, although it was possible Trimethoprim resistance in E. coli Table 3 .
Co-transduction of markers between strains of E. coli K12
Transduction experiments were performed as described in the text. Co-transduction frequencies (x) are expressed in terms of the proportion of transductants examined which inherited the unselected marker. to transduce the tim-1 determinant to CSH61, the transductants were consistently no longer able to act as donors in conjugation experiments and were resistant to MS2 and R17. When attempts were made to transfer Fpro+lac+ from CSH23 into 553.2 carrying tim-1, transconjugants were obtained at a frequency of 9 x per recipient organism. This compared with a frequency of 6 x per recipient organism when transfer was to the parental 553.2. In addition, whilst 100% of 553.2 pro+ transconjugants were R17-sensitive, only 17% of 553.2 tim-1 pro+ transconjugants were R17-sensitive. Thus the presence of tim-1 had a considerable effect on both the donor and recipient ability of a cell in relation to the fertility factor F . This observation will be further discussed later.
Map distances (d; in min) and 95% confidence intervals (CI; in min)
Preliminary mapping of the trimethoprim resistance determinants using conjugation
An R17-sensitive 553.2 derivative carrying tim-1 and F'pro+lac+ was used as donor in a mating with CSH57b. The map positions of the markers carried by CSH57b are shown by Bachmann & Low (1 980). Trimethoprim-resistant transconjugants were obtained at a frequency of 2 x transconjugants per recipient cell, 44% of which had received only ara+ and leu+ in addition to tim-1. When ilv+ transconjugants were selected, the co-inheritance of the unselected markers (ara+, leu+ and tim-I), was ara+ 59%; leu+ 36%; tim-1 12%, suggesting that tim-1 was located on the far side of leu from ara, at about 2 min on the E. coli K12 chromosome. Similar crosses, in which the CSH61 HfrC tim-2 and tim-3 derivatives were used as donors, indicated that tim-2 mapped at about the 1 min region, while tim-3, like tim-1, mapped at about 2 min.
Mapping using PI co-transductwn frequencies
Having determined the approximate map locations of tim-1, tim-2 and tim-3 by conjugation experiments, it was feasible to examine their P 1 co-transduction frequencies with markers positioned close to their apparent locations. Many of the genes positioned at or around 2 min on the E. coli K12 linkage map are concerned with cell wall functions and cell division and are therefore less easily handled than resistance or nutritional markers. In view of this, co- transduction of tim-1, tim-2 and tim-3 with ara, leu and azi was investigated. The co-transduction frequencies of a known for mutation with the same markers was also determined ( Table 3) .
The leu and ara markers are located between 0.2 and 0.3 rnin apart on the E. coli K 12 linkage map (Bachmann & Low, 1980) . However, the map distance between these two markers, calculated using the data obtained from transductional crosses with a CSH57b recipient and the donors mentioned above, varied from 0.21 to 0.39 min. Variations also occurred depending on which of the two markers was selected, a not unusual finding (Bachmann et al., 1976) , which represents a potential source of error in the determination of map distances. Bearing in mind this qualification, a comparison of the co-transduction frequencies of tim-1, tim-2, tim-3 and fol with ara and leu showed that tim-2 mapped at a position very close to that of fol. In contrast, tim-1 showed some linkage with ara and leu, but the low co-transduction frequencies obtained were not consistent with tim-1 being located close tofol. In the case of tim-3 no linkage with ara and leu was detected. When co-transduction frequencies with azi were determined, results obtained were again consistent with tim-2 andfol mapping closely together near leu and ara and at about 1 min from azi, while tim-1 and tim-3 mapped closer to azi than ara or leu. The linkage data obtained are summarized in Fig. 1 .
Possible interaction of tim-1 and azi
When tim-1 transductants were tested as described in Methods for the co-transduction of either aziS or azi', a varying proportion of transductants displayed an 'intermediate' degree of growth on sodium azide. In these cases there was growth which covered only the initial area of the streak; this contrasted with the zero growth obtained with the sensitive control, but was considerably less than that obtained with the resistant control. As this phenomenon was not observed in parallel crosses involving the transduction of tim-2, tim-3 orfol, the presence of tim-1 might in some way be connected with the phenotypic appearance of the transductants on sodium azide. This observation will be discussed later. -1, tim-2 and tim-3 on the E. coli K12 chromosome were not afected by the mechanism of transfer It was possible that the positions taken by tim-1, tim-2 and tim-3 on the E. coli K12 chromosome were influenced by the mechanism of gene transfer from the original strain (i.e. P1 transduction) rather than reflecting the positions which were originally occupied on the chromosome of their respective clinical strains. In order to investigate this, the plasmid RP4 was introduced into each original clinical strain. RP4 is known to be capable of mobilizing the chromosome of E. coli strains at a low frequency, possibly as a result of an integration event following the transposition of Tnl from RP4 to the host cell chromosome (Harayama et al., 1980) . When the clinical strains containing RP4 were crossed with J53.2, trimethoprim-resistant transconjugants were obtained at frequencies of about 5 x per recipient cell. No trimethoprim-resistant colonies were obtained in RP4-control experiments. The map positions taken by tim-1, tim-2 and tim-3 on the E. coli K12 chromosome in the transconjugants produced Trimethoprim resistance in E. coli 91 in RP4-mediated matings were the same as those taken when resistance was originally mobilized from the clinical isolates using P1 transduction. Thus it appeared that these map positions reflected genuine regions of DNA homology between the genomes of the naturally occurring E. coli strains and E. coli K 12.
Evidence that the positions taken by tim
DISCUSSION
The transfer of the chromosomal genes controlling trimethoprim resistance in clinical isolates of E. coli into the laboratory strain E. coli K12 was found to present a number of difficulties. Fewer naturally occurring isolates were sensitive to PI than had been anticipated and, of those which were, only one was resistant to trimethoprim. Only 28 % of the 339 clinical E. coli isolates tested were sensitive to P1 compared with 70% in a survey reported by Robeson et al. (1980) . This group of workers used PlCMclr100 to lysogenize sensitive cells and allow for their selection in a largely resistant population. The method used in this paper was likely to detect o n l i a predominantly sensitive population and this may account for the wide disparity in the results obtained.
It was only possible to produce low titre lysates from the P1-sensitive strains of E. coli which were trimethoprim-resistant. As only about 0.3% of particles in a P1 lysate are transducing particles (Stent & Calendar, 1978) , this considerably reduced the likelihood of the transduction of any particular chromosomal gene compared with the use of a lysate of higher titre. Trimethoprim-resistant transductants were detected less often than other classes of transductants. When coupled with the observation that no trimethoprim-resistant transductants were detected if more than 8 mg trimethoprim 1-l was incorporated into the selection plates, this suggestedthat there were problems related to the expression of the genes conferring resistance in E. coli K12. Restriction of the incoming DNA was shown not to be a significant factor and although the possibility of delayed expression was suggested by the work of Breeze et al. (1975) , our results indicated that incubation prior to plating on trimethoprim-containing medium did not greatly influence the number of resistant transductants obtained. It would therefore seem that there must be some basic differences between 'wild' and 'laboratory' strains of E. coli which affect the ease with which different types of chromosomal resistance to trimethoprim can be expressed.
A possible insight into one of these differences was provided by the influence of the tim-1 determinant on the expression of the fertility factor F. It was not possible to transduce tim-1 into an Hfr donor and retain the Hfr character. In addition, F' plasmids could only be transferred at a reduced frequency into 553.2 carrying tim-1 and a proportion of the transconjugants were insensitive to F-specific bacteriophages. Similar findings have been reported previously : Bushby (1 973) could not demonstrate the transfer of resistance by conjugation in E. coli strains trained to trimethoprim resistance, while Breeze et al. (1975) could not train an E. coli K12 Hfr strain to trimethoprim resistance and retain the Hfr character. One of the main structural components of the outer membrane of Gram-negative bacteria is LPS. It has been suggested that LPS has an essential role in the formation and stabilization of mating pairs in E. coli K12 (Glowacka & Mieczylawa, 1981) and, in addition, that rough cells with defective LPS acquire plasmids at a higher frequency than smooth strains (Okada & Watanabe, 1968 ). An alteration in the LPS component of the membrane might lead to a change in the conjugational ability of the organism and at the same time contribute to the acquisition of trimethoprim resistance.
The possibility that the tim-1 determinant might mediate resistance to trimethoprim by causing an alteration in the cell envelope was supported by its mapped location at about 2 min on the K12 linkage map, among a cluster of genes coding for cell envelope functions, and also by its phenotypic interaction with the azi gene, which is itself thought to be involved in the formation, activity and maintenance of the membrane structure (Yura & Wada, 1968 ). Further detailed biochemical study will obviously be required to elucidate the precise nature of the changes brought about by tim-1, tim-2 and tim-3 in E. coli K12.
One of the original purposes of this work was to investigate genetically whether findings concerning artificially-induced trimethoprim resistance in E. coli K 12 were relevant to chromosomal resistance in naturally occurring clinical strains. Mapping studies indicated that tim-2 was probably afol-type mutation, although the observation that only a reduced MIC was expressqd in the K12 transductants suggested that other factors contributed to the total resistanke in the original clinical strain. In contrast, tim-l and tim-3 mapped at completely different loci compared with fol. It would therefore appear that mechanisms of chromosomal resistance to trimethoprim in E. coli isolates from human infections are considerably more complex and diverse than was indicated by previous studies of E. coli K12 mutants.
